Literature DB >> 18712477

Weighted analyses for cohort sampling designs.

Robert J Gray1.   

Abstract

Weighted analysis methods are considered for cohort sampling designs that allow subsampling of both cases and non-cases, but with cases generally sampled more intensively. The methods fit into the general framework for the analysis of survey sampling designs considered by Lin (Biometrika 87:37-47, 2000). Details are given for applying the general methodology in this setting. In addition to considering proportional hazards regression, methods for evaluating the representativeness of the sample and for estimating event-free probabilities are given. In a small simulation study, the one-sample cumulative hazard estimator and its variance estimator were found to be nearly unbiased, but the true coverage probabilities of confidence intervals computed from these sometimes deviated significantly from the nominal levels. Methods for cross-validation and for bootstrap resampling, which take into account the dependencies in the sample, are also considered.

Mesh:

Year:  2008        PMID: 18712477     DOI: 10.1007/s10985-008-9095-z

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  8 in total

1.  Exposure stratified case-cohort designs.

Authors:  O Borgan; B Langholz; S O Samuelsen; L Goldstein; J Pogoda
Journal:  Lifetime Data Anal       Date:  2000-03       Impact factor: 1.588

2.  A paradigm for class prediction using gene expression profiles.

Authors:  Michael D Radmacher; Lisa M McShane; Richard Simon
Journal:  J Comput Biol       Date:  2002       Impact factor: 1.479

Review 3.  Design options for molecular epidemiology research within cohort studies.

Authors:  Andrew G Rundle; Paolo Vineis; Habibul Ahsan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-08       Impact factor: 4.254

Review 4.  Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting.

Authors:  Alain Dupuy; Richard M Simon
Journal:  J Natl Cancer Inst       Date:  2007-01-17       Impact factor: 13.506

5.  A Z-theorem with Estimated Nuisance Parameters and Correction Note for 'Weighted Likelihood for Semiparametric Models and Two-phase Stratified Samples, with Application to Cox Regression'

Authors:  Norman E Breslow; Jon A Wellner
Journal:  Scand Stat Theory Appl       Date:  2008-03-01       Impact factor: 1.396

Review 6.  Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls.

Authors:  L Rodrigues; B R Kirkwood
Journal:  Int J Epidemiol       Date:  1990-03       Impact factor: 7.196

7.  Robust variance estimation for the case-cohort design.

Authors:  W E Barlow
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

8.  Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.

Authors:  Lori J Goldstein; Robert Gray; Sunil Badve; Barrett H Childs; Carl Yoshizawa; Steve Rowley; Steven Shak; Frederick L Baehner; Peter M Ravdin; Nancy E Davidson; George W Sledge; Edith A Perez; Lawrence N Shulman; Silvana Martino; Joseph A Sparano
Journal:  J Clin Oncol       Date:  2008-08-04       Impact factor: 44.544

  8 in total
  29 in total

1.  Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.

Authors:  Joseph A Sparano; Lori J Goldstein; Barrett H Childs; Steven Shak; Diana Brassard; Sunil Badve; Frederick L Baehner; Roberto Bugarini; Steve Rowley; Edith A Perez; Lawrence N Shulman; Silvana Martino; Nancy E Davidson; Paraic A Kenny; George W Sledge; Robert Gray
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

2.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

3.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

4.  Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).

Authors:  Donna Niedzwiecki; Wendy L Frankel; Alan P Venook; Xing Ye; Paula N Friedman; Richard M Goldberg; Robert J Mayer; Thomas Anthony Colacchio; Jude Marie Mulligan; Timothy S Davison; Eamonn O'Brien; Peter Kerr; Patrick G Johnston; Richard D Kennedy; D Paul Harkin; Richard L Schilsky; Monica M Bertagnolli; Robert S Warren; Federico Innocenti
Journal:  J Clin Oncol       Date:  2016-07-18       Impact factor: 44.544

5.  Neonatal vitamin D status is not associated with later risk of type 1 diabetes: results from two large Danish population-based studies.

Authors:  Ramune Jacobsen; Steffen U Thorsen; Arieh S Cohen; Marika Lundqvist; Peder Frederiksen; Christian B Pipper; Flemming Pociot; Lau C Thygesen; Alberto Ascherio; Jannet Svensson; Berit L Heitmann
Journal:  Diabetologia       Date:  2016-05-30       Impact factor: 10.122

6.  IMPROVING EFFICIENCY IN BIOMARKER INCREMENTAL VALUE EVALUATION UNDER TWO-PHASE DESIGNS.

Authors:  Yingye Zheng; Marshall Brown; Anna Lok; Tianxi Cai
Journal:  Ann Appl Stat       Date:  2017-07-20       Impact factor: 2.083

7.  Resampling Procedures for Making Inference under Nested Case-control Studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

8.  Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.

Authors:  Stephen J Luen; Rebecca Asher; Chee Khoon Lee; Peter Savas; Roswitha Kammler; Patrizia Dell'Orto; Olivia Maria Biasi; David Demanse; Lellean JeBailey; Sinead Dolan; Wolfgang Hackl; Beat Thuerlimann; Giuseppe Viale; Marco Colleoni; Meredith M Regan; Sherene Loi
Journal:  JAMA Oncol       Date:  2018-10-01       Impact factor: 31.777

9.  Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.

Authors:  Alan P Venook; Donna Niedzwiecki; Margarita Lopatin; Xing Ye; Mark Lee; Paula N Friedman; Wendy Frankel; Kim Clark-Langone; Carl Millward; Steven Shak; Richard M Goldberg; Najjia N Mahmoud; Robert S Warren; Richard L Schilsky; Monica M Bertagnolli
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

10.  Population-based absolute risk estimation with survey data.

Authors:  Stephanie A Kovalchik; Ruth M Pfeiffer
Journal:  Lifetime Data Anal       Date:  2013-05-18       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.